A Comparative Study of The Effect of Selectivity of COX-2 Inhibition (Meloxicam & Celecoxib) on Some Cardiovascular RiskMarkers in Patients With Rheumatoid Arthritis. AJPS 2010, 7 (1), 90-105. https://doi.org/10.32947/ajps.v7i1.321.